We consistently observed strong associations between SETBP1 mutations and increased TMB in both tumors (Wilcoxon rank-sum test P = 0.028 and 0.013 for melanoma and NSCLC, respectively; Supplementary Figure 8A, 8B). The gene discussed is SETBP1; the disease is melanoma.